Pulmonary complications of infective endocarditis in intravenous drug users Source: Eur Respir J 2001; 18: Suppl. 33, 521s Year: 2001
Pulmonary onset and complications of intravenous drug users infective endocarditis Source: International Congress 2018 – Diagnosis, prognostication and treatment of pulmonary embolism Year: 2018
Septic pulmonary embolism in intravenous drug users. Source: International Congress 2017 – Pulmonary embolism Year: 2017
Pulmonary pathology in fatal intravenous heroin addicts Source: Eur Respir J 2003; 22: Suppl. 45, 268s Year: 2003
Angiogenic sepsis in intravenous drug abusers Source: Eur Respir J 2003; 22: Suppl. 45, 451s Year: 2003
Severe respiratory illness in an intravenous drug abuser Source: ISSN=ISSN 1810-6838, ISBN=, page=207 Year: 2006
Safety of intravenous amikacin in the treatment of pulmonary non-tuberculous mycobacterial disease Source: Annual Congress 2013 –Non-tuberculous mycobacteria: clinical management Year: 2013
Pulmonary hypertension in patients with infective endocarditis Source: Annual Congress 2011 - Clinical features of pulmonary hypertension Year: 2011
Pharmacokinetics of drugs for non tuberculous mycobacterial lung infections Source: Annual Congress 2012 - Non-tuberculous and tuberculous mycobacterial infections: from epidemiology to clinical findings Year: 2012
Predictors of tuberculosis in injection drug users Source: International Congress 2019 – Tuberculosis and comorbidities Year: 2019
Acute eosinophilic pneumonia due to heroin inhalation Source: International Congress 2018 – Pitfalls in the diagnosis and management of rare diffuse parenchymal lung diseases (DPLDs) Year: 2018
Systemic corticosteroid and inhalation corticosteroid therapy are associated with nontuberculous mycobacterial pulmonary disease Source: International Congress 2015 – Non-tuberculous mycobacteria and molecular microbiology Year: 2015
Pulmonary manifestations in severe strongyloidiasis: Review of 17 cases Source: International Congress 2015 – A morphological view of chest pathology Year: 2015
Evaluation of drug induced liver injury due to anti tuberculous drugs in directly observed daily therapy Source: International Congress 2016 – Tuberculosis: the elderly, the diabetic, the unusual, and the severe Year: 2016
Does previous warfarin treatment effect complications and outcome in hospitalised patients with community-acquired pneumonia? Source: International Congress 2014 – Different interesting issues in respiratory infections: 2 Year: 2014
Barriers to an early switch from intravenous to oral antibiotic therapy in hospitalised patients with CAP Source: Eur Respir J 2013; 41: 123-130 Year: 2013
Efficacy of moxifloxacin instead of ethambutol in the intensive phase of therapy in newly diagnosed pulmonary TB Source: International Congress 2016 – Treatment management options and costs: vitamin D, Matrix metalloproteinases (MMPs), nutrition, and human genetics Year: 2016
Lung injuries after narcotic overdose. Usefulness of MDCT and MRI Source: International Congress 2015 – A morphological view of chest pathology Year: 2015
Sudden deaths amongst inpatients with active pulmonary tuberculosis following commencement of antimicrobial therapy Source: Eur Respir J 2003; 22: Suppl. 45, 158s Year: 2003
Could the early administration of antibiotics before admission improve the prognosis of pneumonia? Source: International Congress 2015 – Pneumonia: determinants of clinical outcomes and potential strategies to improve its management Year: 2015